Viatris Asks FDA Not To Approve Neffy Until Sponsor Conducts More PK/PD Studies

 
• By Brenda Sandburg
  
Anaphylaxis
Viatris says intranasal spray for treatment of anaphylaxis requires more PK/PD studies for approval • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from US FDA Performance Tracker

More from Regulatory Trackers